(BAMNB) Koninklijke BAM Groep - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0000337319
Stock: Construction, Infrastructure, Buildings, Maintenance, PPP
Total Rating 64
Risk 61
Buy Signal 0.14
Dividends
| Dividend Yield | 4.03% |
| Yield on Cost 5y | 16.03% |
| Yield CAGR 5y | 29.10% |
| Payout Consistency | 67.6% |
| Payout Ratio | 65.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.8% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.35 |
| Alpha | 120.91 |
| Character TTM | |
|---|---|
| Beta | 0.309 |
| Beta Downside | 0.533 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.66% |
| CAGR/Max DD | 2.77 |
Description: BAMNB Koninklijke BAM Groep January 14, 2026
Koninklijke BAM Groep NV (ticker BAMNB) is a Dutch-based, globally active construction and property group that operates across civil engineering, building, and public-private partnership (PPP) markets.
Through its subsidiaries, BAM delivers a broad portfolio that includes road, rail, bridge, tunnel, cable, sewage and energy infrastructure projects, as well as prefabricated and custom low-rise and mid-rise buildings, student housing, retirement homes, and the Flow-brand wooden homes. The firm also designs, builds, maintains and operates commercial, healthcare, educational, leisure, industrial and airport facilities.
Key recent metrics (FY 2023): revenue €8.1 bn, order backlog €12.5 bn (≈ 155 % of annual revenue), adjusted EBIT margin 5.8 %, and a free-cash-flow conversion of 85 %. The business is sensitive to European infrastructure spending cycles, especially EU-driven green-transition projects and the resurgence of PPP pipelines after the pandemic-induced slowdown. Construction cost inflation and labour shortages remain material risk factors that can compress margins.
For a deeper, data-rich assessment of BAM’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a look.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 298.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 12.20 > 1.0 |
| NWC/Revenue: -0.54% < 20% (prev -0.97%; Δ 0.42% < -1%) |
| CFO/TA 0.08 > 3% & CFO 320.4m > Net Income 298.5m |
| Net Debt (-153.2m) to EBITDA (597.4m): -0.26 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (267.1m) vs 12m ago -3.21% < -2% |
| Gross Margin: 16.89% > 18% (prev 0.33%; Δ 1656 % > 0.5%) |
| Asset Turnover: 337.8% > 50% (prev 238.9%; Δ 98.91% > 0%) |
| Interest Coverage Ratio: 13.84 > 6 (EBITDA TTM 597.4m / Interest Expense TTM 24.0m) |
Altman Z'' 0.87
| A: -0.02 (Total Current Assets 2.53b - Total Current Liabilities 2.60b) / Total Assets 3.85b |
| B: 0.03 (Retained Earnings 122.4m / Total Assets 3.85b) |
| C: 0.09 (EBIT TTM 331.8m / Avg Total Assets 3.89b) |
| D: 0.30 (Book Value of Equity 885.9m / Total Liabilities 2.96b) |
| Altman-Z'' Score: 0.87 = B |
Beneish M -1.96
| DSRI: 0.94 (Receivables 1.44b/1.10b, Revenue 13.14b/9.39b) |
| GMI: 1.96 (GM 16.89% / 33.17%) |
| AQI: 0.94 (AQ_t 0.22 / AQ_t-1 0.23) |
| SGI: 1.40 (Revenue 13.14b / 9.39b) |
| TATA: -0.01 (NI 298.5m - CFO 320.4m) / TA 3.85b) |
| Beneish M-Score: -1.96 (Cap -4..+1) = B |
What is the price of BAMNB shares?
As of February 07, 2026, the stock is trading at EUR 9.27 with a total of 577,161 shares traded.
Over the past week, the price has changed by +4.86%, over one month by -2.52%, over three months by +22.13% and over the past year by +133.56%.
Over the past week, the price has changed by +4.86%, over one month by -2.52%, over three months by +22.13% and over the past year by +133.56%.
Is BAMNB a buy, sell or hold?
Koninklijke BAM Groep has no consensus analysts rating.
What are the forecasts/targets for the BAMNB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.4 | 1.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.1 | 51.6% |
BAMNB Fundamental Data Overview February 03, 2026
Market Cap USD = 2.71b (2.30b EUR * 1.1801 EUR.USD)
P/E Trailing = 21.561
P/E Forward = 10.352
P/S = 0.3434
P/B = 2.5785
Revenue TTM = 13.14b EUR
EBIT TTM = 331.8m EUR
EBITDA TTM = 597.4m EUR
Long Term Debt = 82.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 90.8m EUR (from shortTermDebt, last quarter)
Debt = 347.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -153.2m EUR (from netDebt column, last quarter)
Enterprise Value = 2.14b EUR (2.30b + Debt 347.4m - CCE 500.6m)
Interest Coverage Ratio = 13.84 (Ebit TTM 331.8m / Interest Expense TTM 24.0m)
EV/FCF = 8.14x (Enterprise Value 2.14b / FCF TTM 263.1m)
FCF Yield = 12.28% (FCF TTM 263.1m / Enterprise Value 2.14b)
FCF Margin = 2.00% (FCF TTM 263.1m / Revenue TTM 13.14b)
Net Margin = 2.27% (Net Income TTM 298.5m / Revenue TTM 13.14b)
Gross Margin = 16.89% ((Revenue TTM 13.14b - Cost of Revenue TTM 10.92b) / Revenue TTM)
Gross Margin QoQ = 27.87% (prev 6.74%)
Tobins Q-Ratio = 0.56 (Enterprise Value 2.14b / Total Assets 3.85b)
Interest Expense / Debt = 1.96% (Interest Expense 6.80m / Debt 347.4m)
Taxrate = 9.86% (11.1m / 112.6m)
NOPAT = 299.1m (EBIT 331.8m * (1 - 9.86%))
Current Ratio = 0.97 (Total Current Assets 2.53b / Total Current Liabilities 2.60b)
Debt / Equity = 0.39 (Debt 347.4m / totalStockholderEquity, last quarter 885.9m)
Debt / EBITDA = -0.26 (Net Debt -153.2m / EBITDA 597.4m)
Debt / FCF = -0.58 (Net Debt -153.2m / FCF TTM 263.1m)
Total Stockholder Equity = 911.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.68% (Net Income 298.5m / Total Assets 3.85b)
RoE = 32.75% (Net Income TTM 298.5m / Total Stockholder Equity 911.5m)
RoCE = 33.39% (EBIT 331.8m / Capital Employed (Equity 911.5m + L.T.Debt 82.4m))
RoIC = 30.47% (NOPAT 299.1m / Invested Capital 981.7m)
WACC = 6.36% (E(2.30b)/V(2.64b) * Re(7.05%) + D(347.4m)/V(2.64b) * Rd(1.96%) * (1-Tc(0.10)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.48%
[DCF Debug] Terminal Value 78.35% ; FCFF base≈263.1m ; Y1≈172.7m ; Y5≈78.8m
Fair Price DCF = 9.06 (EV 2.20b - Net Debt -153.2m = Equity 2.35b / Shares 259.7m; r=6.36% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 34.95 | Revenue CAGR: 0.67% | SUE: 2.12 | # QB: 1
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=-0.037 | Revisions Net=+1 | Growth EPS=+15.5% | Growth Revenue=+3.4%
P/E Trailing = 21.561
P/E Forward = 10.352
P/S = 0.3434
P/B = 2.5785
Revenue TTM = 13.14b EUR
EBIT TTM = 331.8m EUR
EBITDA TTM = 597.4m EUR
Long Term Debt = 82.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 90.8m EUR (from shortTermDebt, last quarter)
Debt = 347.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -153.2m EUR (from netDebt column, last quarter)
Enterprise Value = 2.14b EUR (2.30b + Debt 347.4m - CCE 500.6m)
Interest Coverage Ratio = 13.84 (Ebit TTM 331.8m / Interest Expense TTM 24.0m)
EV/FCF = 8.14x (Enterprise Value 2.14b / FCF TTM 263.1m)
FCF Yield = 12.28% (FCF TTM 263.1m / Enterprise Value 2.14b)
FCF Margin = 2.00% (FCF TTM 263.1m / Revenue TTM 13.14b)
Net Margin = 2.27% (Net Income TTM 298.5m / Revenue TTM 13.14b)
Gross Margin = 16.89% ((Revenue TTM 13.14b - Cost of Revenue TTM 10.92b) / Revenue TTM)
Gross Margin QoQ = 27.87% (prev 6.74%)
Tobins Q-Ratio = 0.56 (Enterprise Value 2.14b / Total Assets 3.85b)
Interest Expense / Debt = 1.96% (Interest Expense 6.80m / Debt 347.4m)
Taxrate = 9.86% (11.1m / 112.6m)
NOPAT = 299.1m (EBIT 331.8m * (1 - 9.86%))
Current Ratio = 0.97 (Total Current Assets 2.53b / Total Current Liabilities 2.60b)
Debt / Equity = 0.39 (Debt 347.4m / totalStockholderEquity, last quarter 885.9m)
Debt / EBITDA = -0.26 (Net Debt -153.2m / EBITDA 597.4m)
Debt / FCF = -0.58 (Net Debt -153.2m / FCF TTM 263.1m)
Total Stockholder Equity = 911.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.68% (Net Income 298.5m / Total Assets 3.85b)
RoE = 32.75% (Net Income TTM 298.5m / Total Stockholder Equity 911.5m)
RoCE = 33.39% (EBIT 331.8m / Capital Employed (Equity 911.5m + L.T.Debt 82.4m))
RoIC = 30.47% (NOPAT 299.1m / Invested Capital 981.7m)
WACC = 6.36% (E(2.30b)/V(2.64b) * Re(7.05%) + D(347.4m)/V(2.64b) * Rd(1.96%) * (1-Tc(0.10)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.48%
[DCF Debug] Terminal Value 78.35% ; FCFF base≈263.1m ; Y1≈172.7m ; Y5≈78.8m
Fair Price DCF = 9.06 (EV 2.20b - Net Debt -153.2m = Equity 2.35b / Shares 259.7m; r=6.36% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 0.12 | EPS CAGR: -22.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 34.95 | Revenue CAGR: 0.67% | SUE: 2.12 | # QB: 1
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=-0.037 | Revisions Net=+1 | Growth EPS=+15.5% | Growth Revenue=+3.4%